Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI118642

Identification of cardiac myosin peptides capable of inducing autoimmune myocarditis in BALB/c mice.

C L Pummerer, K Luze, G Grässl, K Bachmaier, F Offner, S K Burrell, D M Lenz, T J Zamborelli, J M Penninger, and N Neu

Department of Pediatrics, University of Innsbruck, Medical School, Austria.

Find articles by Pummerer, C. in: PubMed | Google Scholar

Department of Pediatrics, University of Innsbruck, Medical School, Austria.

Find articles by Luze, K. in: PubMed | Google Scholar

Department of Pediatrics, University of Innsbruck, Medical School, Austria.

Find articles by Grässl, G. in: PubMed | Google Scholar

Department of Pediatrics, University of Innsbruck, Medical School, Austria.

Find articles by Bachmaier, K. in: PubMed | Google Scholar

Department of Pediatrics, University of Innsbruck, Medical School, Austria.

Find articles by Offner, F. in: PubMed | Google Scholar

Department of Pediatrics, University of Innsbruck, Medical School, Austria.

Find articles by Burrell, S. in: PubMed | Google Scholar

Department of Pediatrics, University of Innsbruck, Medical School, Austria.

Find articles by Lenz, D. in: PubMed | Google Scholar

Department of Pediatrics, University of Innsbruck, Medical School, Austria.

Find articles by Zamborelli, T. in: PubMed | Google Scholar

Department of Pediatrics, University of Innsbruck, Medical School, Austria.

Find articles by Penninger, J. in: PubMed | Google Scholar

Department of Pediatrics, University of Innsbruck, Medical School, Austria.

Find articles by Neu, N. in: PubMed | Google Scholar

Published May 1, 1996 - More info

Published in Volume 97, Issue 9 on May 1, 1996
J Clin Invest. 1996;97(9):2057–2062. https://doi.org/10.1172/JCI118642.
© 1996 The American Society for Clinical Investigation
Published May 1, 1996 - Version history
View PDF
Abstract

Immunization with cardiac myosin induces T cell-mediated myocarditis in genetically predisposed mice and serves as a model for autoimmune heart disease. This study was undertaken to identify pathogenic epitopes on the myosin molecule. Our approach was based on the comparison of the pathogenicity between cardiac (alpha-)myosin and soleus muscle (beta-)myosin. We show that alpha-myosin is the immunodominant isoform and induces myocarditis at high severity and prevalence whereas beta-myosin induces little disease. Therefore the immunodominant epitopes of alpha-myosin must reside in regions of different amino acid sequence between alpha- and beta-myosin isoforms. Cardiac myosin peptides corresponding to these regions of difference were synthesized and tested for their ability to induce inflammatory heart disease. Three pathogenic peptides were identified. One peptide that is located in the head portion of the molecule induced severe myocarditis, whereas two others that reside in the rod portion possessed only minor pathogenicity. The identification of pathogenic epitopes on the cardiac myosin molecule will allow detailed studies on the recognition of this antigen by the immune system and might be used to downmodulate ongoing heart disease.

Version history
  • Version 1 (May 1, 1996): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts